Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» $13 Billion Opportunity: 5 Companies That Could Dominate the Alzheimer's Disease Market
$13 Billion Opportunity: 5 Companies That Could Dominate the Alzheimer's Disease Market
$13 Billion Opportunity: 5 Companies That Could Dominate the Alzheimer's Disease Market
Submitted by
admin
on November 21, 2016 - 2:35pm
Source:
Motley Fool
News Tags:
Alzheimer's disease
AstraZeneca
Biogen
Eli Lilly
Merck
Roche
BACE inhibitors
Headline:
$13 Billion Opportunity: 5 Companies That Could Dominate the Alzheimer's Disease Market
Do Not Allow Advertisers to Use My Personal information
